Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2019-08-19 | John R Sylvester was appointed as a director of the Company in July 2019. He is currently serving as Chief Commercial Officer of BTG plc, which he joined in 2011 and has had roles leading both their Interventional Oncology and Interventional Vascular businesses as well as a period as Chief Development Officer accountable for Strategy, M&A and Market access. ... John graduated with joint honours in Biochemistry and Applied Molecular Biology from the University of Manchester Institute of Science and Technology (U.M.I.S.T.) |
| 2020-11-02 | John graduated with joint honours in Biochemistry and Applied Molecular Biology from the University of Manchester Institute of Science and Technology (U.M.I.S.T.) |
| 2021-04-07 | John graduated with joint honors in Biochemistry and Applied Molecular Biology from the University of Manchester. |
Data sourced from SEC filings. Last updated: 2025-08-30